Wojciech K Kasprzak
Overview
Explore the profile of Wojciech K Kasprzak including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
786
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lin Z, Bashirova A, Viard M, Garner L, Quastel M, Beiersdorfer M, et al.
Nat Immunol
. 2023 Jun;
24(7):1087-1097.
PMID: 37264229
Human leukocyte antigen (HLA)-E binds epitopes derived from HLA-A, HLA-B, HLA-C and HLA-G signal peptides (SPs) and serves as a ligand for CD94/NKG2A and CD94/NKG2C receptors expressed on natural killer...
2.
Olenginski L, Kasprzak W, Attionu S, Shapiro B, Dayie T
Molecules
. 2023 Feb;
28(4).
PMID: 36838792
The global burden imposed by hepatitis B virus (HBV) infection necessitates the discovery and design of novel antiviral drugs to complement existing treatments. One attractive and underexploited therapeutic target is...
3.
Kasprzak W, Shapiro B
Methods Mol Biol
. 2022 Oct;
2568:75-101.
PMID: 36227563
Recognition of the growing importance of RNA as a target for therapeutic or diagnostic ligands brings the importance of computational predictions of docking poses to such receptors to the forefront....
4.
Olenginski L, Kasprzak W, Bergonzo C, Shapiro B, Dayie T
J Mol Biol
. 2022 May;
434(18):167633.
PMID: 35595167
Human hepatitis B virus (HBV) replication is initiated by the binding of the viral polymerase (P) to epsilon (ε), an ≈85-nucleotide (nt) cis-acting regulatory stem-loop RNA located at the 5'-end...
5.
Johnson P, Kasprzak W, Shapiro B, Simon A
Nucleic Acids Res
. 2022 Feb;
50(3):1601-1619.
PMID: 35104872
Canonical eukaryotic mRNA translation requires 5'cap recognition by initiation factor 4E (eIF4E). In contrast, many positive-strand RNA virus genomes lack a 5'cap and promote translation by non-canonical mechanisms. Among plant...
6.
Swain M, Ageeli A, Kasprzak W, Li M, Miller J, Sztuba-Solinska J, et al.
Nucleic Acids Res
. 2021 Dec;
49(22):13179-13193.
PMID: 34871450
Cellular and virus-coded long non-coding (lnc) RNAs support multiple roles related to biological and pathological processes. Several lncRNAs sequester their 3' termini to evade cellular degradation machinery, thereby supporting disease...
7.
Dao B, Viard M, Martins A, Kasprzak W, Shapiro B, Afonin K
DNA RNA Nanotechnol
. 2021 Jul;
2(1):1-12.
PMID: 34322586
Proteins are considered to be the key players in structure, function, and metabolic regulation of our bodies. The mechanisms used in conventional therapies often rely on inhibition of proteins with...
8.
Halman J, Satterwhite E, Smollett J, Bindewald E, Parlea L, Viard M, et al.
RNA Dis
. 2021 Jul;
4.
PMID: 34307841
The targeted and conditional activation of pharmaceuticals is an increasingly important feature in modern personalized medicine. Nucleic acid nanoparticles show tremendous potential in this exploit due to their programmability and...
9.
LeBlanc R, Kasprzak W, Longhini A, Olenginski L, Abulwerdi F, Ginocchio S, et al.
J Biomol Struct Dyn
. 2021 Jun;
40(20):9761-9773.
PMID: 34155954
Initiation of protein-primed (-) strand DNA synthesis in hepatitis B virus (HBV) requires interaction of the viral polymerase with a -acting regulatory signal, designated epsilon (ε), located at the 5'-end...
10.
Zakrevsky P, Kasprzak W, Heinz W, Wu W, Khant H, Bindewald E, et al.
Nanoscale
. 2020 Jan;
12(4):2555-2568.
PMID: 31932830
Using RNA as a material for nanoparticle construction provides control over particle size and shape at the nano-scale. RNA nano-architectures have shown promise as delivery vehicles for RNA interference (RNAi)...